Berkshire Hathaway 13F holdings, Q4 2010
Holdings as of December 31, 2010 · filings on SEC EDGAR · latest filing →
Berkshire Hathaway disclosed 25 US equity positions worth $52.6bn in its Q4 2010 13F filing. The largest position was KO at 25.0% of the reported book, followed by WFC and AXP. Against the Q3 2010 filing, it opened 0 new positions, added to 0 and reduced 11 among the top 25 holdings.
What did Berkshire Hathaway own in Q4 2010? Top 25 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2010 |
|---|---|---|---|---|---|---|---|
| 1 | KO Coca Cola | Consumer Defensive | 25.0% | $13.2bn | 200,000,000 | -17% | reduced |
| 2 | WFC Co. Del | Financial Services | 20.2% | $10.6bn | 342,623,925 | -16% | reduced |
| 3 | AXP Co | Financial Services | 12.4% | $6.5bn | 151,610,700 | -10% | reduced |
| 4 | PG Co | Consumer Defensive | 9.4% | $4.9bn | 76,766,036 | -21% | reduced |
| 5 | Kraft Foods Inc | 6.3% | $3.3bn | 105,214,584 | -23% | reduced | |
| 6 | JNJ Johnson | Healthcare | 5.0% | $2.6bn | 42,624,563 | -27% | reduced |
| 7 | WMT Inc | Consumer Defensive | 4.0% | $2.1bn | 39,037,142 | -0% | held |
| 8 | Wesco Finl Corp | 4.0% | $2.1bn | 5,703,087 | 0% | held | |
| 9 | COP ConocoPhillips | Energy | 3.8% | $2.0bn | 29,109,637 | -0% | held |
| 10 | USB US Bancorp | Financial Services | 3.5% | $1.9bn | 69,039,426 | -25% | reduced |
| 11 | Co | 1.4% | $759.4m | 1,727,765 | -0% | held | |
| 12 | MCO Moody's | Financial Services | 1.4% | $754.1m | 28,415,250 | -2% | reduced |
| 13 | MTB Corporation | Financial Services | 0.9% | $466.9m | 5,363,821 | -0% | held |
| 14 | COST Corp | Consumer Defensive | 0.6% | $312.9m | 4,333,363 | 0% | held |
| 15 | USG Corporation | 0.5% | $287.3m | 17,072,192 | 0% | held | |
| 16 | TMK Torchmark Corp | 0.3% | $168.7m | 2,823,879 | -16% | reduced | |
| 17 | GE Co | Industrials | 0.3% | $142.3m | 7,777,900 | 0% | held |
| 18 | SNY Sanofi Aventis | 0.2% | $131.0m | 4,063,675 | -0% | held | |
| 19 | UPS Service Inc | Industrials | 0.2% | $103.7m | 1,429,200 | 0% | held |
| 20 | GlaxoSmithKline | 0.1% | $59.2m | 1,510,500 | 0% | held | |
| 21 | BNY Mellon Corp | Financial Services | 0.1% | $54.2m | 1,793,915 | -55% | reduced |
| 22 | EXMOC Corp | 0.1% | $30.8m | 421,800 | 0% | held | |
| 23 | Company LTD. CLA | 0.1% | $29.9m | 636,600 | 0% | held | |
| 24 | Gannett Inc | 0.0% | $26.3m | 1,740,231 | 0% | held | |
| 25 | Co | 0.0% | $13.8m | 1,538,377 | -16% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.